Beryl Drugs Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2015. For the quarter, the company reported net sales or revenue from operations of INR 28,428,000 compared to INR 28,560,000 a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,054,000 compared to INR 1,632,000 a year ago. Profit from ordinary activities before tax was INR 577,000 compared to INR 919,000 a year ago. Net profit was INR 377,000 or INR 0.074 per basic and diluted share compared to INR 619,000 or INR 0.122 per basic and diluted share a year ago.

For the nine months period, the company reported net sales or revenue from operations of INR 115,003,000 compared to INR 98,329,000 a year ago. Profit from operations before other income, finance costs and exceptional items was INR 5,525,000 compared to INR 5,585,000 a year ago. Profit from ordinary activities before tax was INR 3,941,000 compared to INR 3,670,000 a year ago. Net profit was INR 3,141,000 or INR 0.619 per basic and diluted share compared to INR 2,870,000 or INR 0.566 per basic and diluted share a year ago.